Health authorities in Buea, Cameroon, have confirmed a case of Mpox in the South-West region on Friday, June 5, 2026. The Ministry of Public Health has mobilized national epidemiological surveillance to ensure early detection and community protection, while local health facilities have been ordered to strengthen monitoring protocols.
Mpox Confirmation in Buea Triggers Surveillance

Shifting Standards in Addiction Medicine
Clinical Indicators and the Scale of Substance Use Disorders
- Intoxication: Immediate, short-term effects including feeling sleepy, calm, or excited, which can impair judgment and physical functioning.
- Withdrawal: Unpleasant symptoms that emerge as a substance leaves the body, such as nausea, vomiting, diarrhea, sweating, muscle cramping, or mood changes.
- Mild: 2–3 symptoms met.
- Moderate: 4–5 symptoms met.
- Severe: 6 or more symptoms met.
| Disorder Type | Reported Prevalence (Millions) |
|---|---|
| Opioid Use Disorder | 6 million |
| Marijuana Use Disorder | 6 million |
| Alcohol Use Disorder | 5 million |
| Prescription Pain Reliever Disorder | 4 million |
| Substance Use Disorder (General) | 4 million |
| Cocaine Use Disorder | 1 million |
| Methamphetamine Use Disorder | 1 million |


















